Carpal tunnel syndrom. Carpal tunnel syndrome
Conditions
Interventions
Intervention 1: Intervention group: Injection of 2 ml of Dextrose water 5% (Samen Pharmaceuticals, Iran) with a 25 gauge needle, in-plane method using a 13 MHz prop of the SONOSITE ultrasound device.
Sponsors
Kashan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
30 Years to 65 Years
Inclusion criteria
Inclusion criteria: Patients aged 30-65 with mild to moderate carpal tunnel syndrome At least 3 months have passed since the onset of symptoms. Has not responded to conservative treatments including splinting, lifestyle modification, and energy preservation techniques Diagnosis of mild-to-moderate severity of carpal tunnel syndrome based on electrodiagnostic criteria
Exclusion criteria
Exclusion criteria: Previous history of polyneuropathy, symptomatic radiculopathy, brachial plexopathy, thoracic outlet syndrome History of wrist surgery or intralesional steroid injection within the past year Rheumatic diseases, fractures or deformities at the injection site Thenar atrophy and severe CTS Pregnancy, coagulopathy, and hypercoagulable conditions Neoplasm or skin infection at the injection site, sensitivity to corticosteroids
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Boston Questionnaire-Symptom Severity scores in the two groups treated with perineural steroid injection and prolotherapy. Timepoint: At the beginning of the study and then 1 and 4 months after the intervention. Method of measurement: Boston Questionnaire-Symptom Severity Questionnaire.;Boston Questionnaire-Functional status scores in the two groups treated with perineural steroid injection and prolotherapy. Timepoint: At the beginning of the study and then 1 and 4 months after the intervention. Method of measurement: Boston Questionnaire- Functional status Questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Average pain intensity using the Visual Analog Scale in the two groups treated with perineural steroid injection and prolotherapy. Timepoint: At the beginning of the study and then 1 and 4 months after the intervention. Method of measurement: Visual Analog Scale Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSareh Sokout Arani
Kashan University of Medical Sciences
Outcome results
None listed